POINT BIOPHARMA GLOBAL INC (PNT)
US7305411099 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 1.09M | N/A | |||
| Cash Equivalents | 21.60M | 286.40M | 238.80M | 10.50M | 0.00 | |||
| Marketable Securities | 317.60M | 238.80M | N/A | N/A | N/A | |||
| Receivables | 9.40M | 100.00K | 100.00K | 100.00K | N/A | |||
| Other Current Assets | 4.70M | 5.50M | 5.00M | 1.80M | 0.00 | |||
| Total Current Assets | 353.20M | 530.80M | 243.80M | 12.40M | 0.00 | |||
| Non-Current Assets | ||||||||
| PPE Net | 59.50M | 31.40M | 19.40M | 9.80M | 0.00 | |||
| Investments And Advances | 59.80M | 16.10M | N/A | 135.71M | N/A | |||
| Total Non-Current Assets | 124.50M | 47.50M | 19.50M | 9.80M | N/A | |||
| TOTAL ASSETS | 477.70M | 578.30M | 263.30M | 22.20M | 0.00 | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.00M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 15.50M | 19.10M | 6.00M | 1.50M | 0.00 | |||
| Accounts Payable | 8.90M | 7.70M | 1.70M | 3.60M | 0.00 | |||
| Other Current Liabilities | 13.30M | 52.90M | 300.00K | 100.00K | N/A | |||
| Total Current Liabilities | 38.70M | 79.70M | 8.00M | 5.20M | 0.00 | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.10M | 0.00 | 0.00 | 3.60M | 0.00 | |||
| Deferred Taxes/Income | N/A | 0.00 | 100.00K | N/A | N/A | |||
| Other Non-Current Liabilities | 10.80M | 11.60M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 14.80M | 11.70M | 0.00 | 3.50M | N/A | |||
| TOTAL LIABILITIES | 53.50M | 91.40M | 8.00M | 8.70M | 0.00 | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -27.70M | 39.00M | -59.30M | -13.40M | 0.00 | |||
| Additional Paid In Capital | 453.30M | 448.40M | 314.50M | 26.80M | 0.00 | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.40M | -500.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 105.80M | 105.60M | 90.10M | 90.10M | 90.10M | |||
| Tangible Book Value per Share | 4.01 | 4.61 | 2.83 | 0.15 | 0.00 | |||
| Total Shareholders' Equity | 424.20M | 487.00M | 255.20M | 13.50M | 0.00 | |||
| TOTAL LIABILITIES AND EQUITY | 477.70M | 578.30M | 263.30M | 22.20M | 0.00 | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | N/A | N/A | 0.27 | N/A | |||
| Current Ratio | 9.13 | 6.66 | 30.48 | 2.38 | N/A | |||
| Return On Assets (ROA) | 20.22% | 17.00% | -17.43% | -60.36% | N/A | |||
| Return On Equity (ROE) | 22.77% | 20.18% | -17.99% | -99.26% | N/A | |||
| Return On Invested Capital (ROIC) | 18.63% | 19.09% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 81.93% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 81.93% | N/A | N/A | N/A | N/A | |||
All data in USD